Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation and Feasibility of Patient Self-sampling of HPV for Cervical Cancer Screening

NCT05600283 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05600283
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05600283 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation and Feasibility of Patient Self-sampling of HPV for Cervical Cancer Screening
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Completed
Start date
November 16, 2022
Completion date
June 4, 2024
Enrollment
222 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

human papilloma virus